Episode Details
Back to Episodes
AstraZeneca $1.5B Cancer Investment, Aquamarine Light Show Over Spain, Neuralink approved for 2nd implant, Spinal Cord Recovery Breakthrough, and more...
Published 1 year, 10 months ago
Description
(0:10): AstraZeneca to Invest $1.5B in Singapore for Revolutionary Cancer Drug Manufacturing Facility
(1:43): Stunning Aquamarine Light Show Over Spain and Portugal Highlights Urgency for Better Space Object Detection
(3:29): Neuralink Gains FDA Nod for Second Human Brain Implant, Targets 10 Patients by Year-End
(5:31): Breakthrough Electrical Stimulation Device Offers New Hope for Spinal Cord Injury Recovery
(8:07): Groundbreaking Research Reveals Superheated Core of 'Warm Neptune' WASP-107 b, Challenging Planet Formation Theories
To subscribe visit https://www.brief.news.
For more updates in your inbox each morning visit www.brief.news.
Image credit: Quartz
(1:43): Stunning Aquamarine Light Show Over Spain and Portugal Highlights Urgency for Better Space Object Detection
(3:29): Neuralink Gains FDA Nod for Second Human Brain Implant, Targets 10 Patients by Year-End
(5:31): Breakthrough Electrical Stimulation Device Offers New Hope for Spinal Cord Injury Recovery
(8:07): Groundbreaking Research Reveals Superheated Core of 'Warm Neptune' WASP-107 b, Challenging Planet Formation Theories
To subscribe visit https://www.brief.news.
For more updates in your inbox each morning visit www.brief.news.
Image credit: Quartz